Nasal Spray Significantly Accelerates Respiratory Virus Clearance in Phase IIa Clinical Study

ENA Respiratory announced that INNA-051, a first-in-class, broad-spectrum, innate immunomodulator in development for the prophylaxis of respiratory viral infections, was found to significantly impact the course of viral infection in a Phase IIa flu challenge study.